Elucidata Briefing Note Axendia was briefed by Abhishek Jha, Co-Founder and CEO at Elucidata. The company was founded a decade ago out of Jha’s experience as a computational […]
Not a SaaS Play: How Elucidata is Rethinking Life Sciences Data Services Read More »
Dotmatics Briefing Note Axendia was briefed by Steve Tharp, President, and Kalim Saliba, Chief Product Officer, at Dotmatics, a Siemens company. Dotmatics provides R&D software and data management
Bridging Scientific Intelligence Across The Product and Process Lifecycle Read More »
Cycle Labs Briefing Note Axendia was briefed by Josh Owen, Founder, President and Executive Chair, at Cycle Labs, an organization focused on addressing a persistent and growing challenge across
An End-to-End Test Automation Platform for Enterprise Supply Chain Systems Read More »
Revvity Signals Briefing Note Axendia was recently briefed by Chris Stumpf, Director of Drug Discovery Informatics Solutions, and Diana Tran, Sr. Product Marketing Specialist, of
Unifying Digital Tools for Modern Drug Discovery Read More »
Benchtalk Boston 2025 Event Brief Benchling hosted over 500 participants – including customers, partners, prospects and analysts at Benchtalk 2025 Boston, its annual industry event showcasing
Spanning Research, Development and GxP-Regulated Environments Read More »
Tulip Operations Calling 2025 Event Brief Tulip’s third annual Operations Calling event drew over 600 attendees to Somerville, MA — the company’s largest and most energetic
Continuous Transformation on the Frontline Read More »
Highbyte DataOps Days Boston Event Brief HighByte hosted its third of three 2025 U.S. DataOps Days at The Engine in Cambridge, MA, gathering roughly 45
Industrial DataOps: The Backbone of AI-Ready Manufacturing Data Read More »
Sapio Sciences Briefing Note Axendia was recently briefed by Mike Hampton, Chief Commercial Officer, and Rob Brown, VP and Head of the Scientific Office, at Sapio Sciences.
Sapio Introduces The Electronic Notebook That Thinks Like A Scientist Read More »
The FDA’s remote regulatory assessments (RRAs) are no longer temporary pandemic measures. Over the past few years, the agency has made it clear that it
Is Your Lab Ready for the FDA’s Remote Data Access Era? Read More »
Axendia’s Event Brief of Benchling Development Summit The 2025 Benchling Development Summit, held in June 2025, brought together over 40 senior biopharma leaders at the
How Biopharma is Digitally Transforming to Accelerate Development Read More »
